November 2, 2022
A collaborative research team at the University of Cincinnati has received a $3.5 million National Institutes of Health grant to examine how current HIV medications are affected by alcohol use alone or in combination with fentanyl.
November 15, 2022
The University of Cincinnati's Randall Wickett spoke with Cosmetics Design Asia about the importance of cosmetics industries being able to verify claims about their products and new technology that will allow the industry to do so.
April 29, 2022
The University of Cincinnati's Jill Boone was featured in a Local 12 story on the impact of staffing issues at local pharmacies.
July 11, 2022
Over decades of ups and downs, the hard work of University of Cincinnati alumnus John Drach paid off when the FDA approved a new drug he helped develop to treat cytomegalovirus.
August 10, 2022
University of Cincinnati researchers Jason Gardner and Matthew Robson are studying whether targeting an inflammation pathway that affects burns and traumatic brain injuries can be an effective treatment for both conditions.
July 28, 2022
Siblings Ally and Adam Klaserner are current students in the James L. Winkle College of Pharmacy, and their parents John and Lorrie are alumni of the UC pharmacy program.
March 22, 2023
Local 12 highlighted the University of Cincinnati's Bingfang Yan, who recently received a a $2.5 million National Institutes of Health grant to study how COVID-19 therapeutics can work together to create more effective and safe treatments for patients.
March 15, 2023
The University of Cincinnati's Cosmetic Science program is celebrating its 50th anniversary this academic year and is continuing to grow and adapt to best prepare students for careers in the industry.
March 15, 2023
In celebration of the University of Cincinnati's Cosmetic Science program's 50th anniversary, four alumni share their experiences with the program and how it prepared them for careers in the industry.
March 16, 2023
The University of Cincinnati's Bingfang Yan's research team has received a $2.5 million National Institutes of Health grant to answer the question of how FDA-approved COVID-19 therapeutics can work together to create more effective and safe treatments for patients.